Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis
ConclusionsICI-mediated myocarditis is potentially fatal and leads to permanent interruption of life-saving cancer therapy. The current data suggest that re-introduction may be considered in low-grade patients; however, a better definition of the diagnosis and grading is needed.Graphic abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Cardiology | Gastric (Stomach) Cancer | Gastroenterology | Heart | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | Myocarditis